![](/img/cover-not-exists.png)
PD-013 * A study level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors (EGFRIs) vs bevacizumab in patients with metastatic colorectal cancer (mCRC)
Heinemann, V., Rivera, F., O'Neill, B., Koukakis, R., Terwey, J. H., Douillard, J. Y.Volume:
26
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv234.12
Date:
June, 2015
File:
PDF, 35 KB
2015